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journal homepage: www.keaipubl ishing.com/WJOHNS; www.wjent .orgEditorialIntroductionThis special issue on cochlear implants is dedicated post-
humously to William F. House, M.D., the Father of Neuro-
tology. Dr. House initiated the first national clinical trial on
cochlear implants. I was privileged to be one of his fellows
and to be included in this first Co-Investigator group and
implanted our first patient in 1979. This led to our
involvement as an FDA Consultant and later FDA ENT De-
vices Panel member. This clinical trialled to the first ever
FDA approval for cochlear implants and opened the door for
unprecedented advances in the treatment of deafness and
hearing loss.
Dr. Ingeborg Hochmair was working in parallel with Dr.
House from the very earliest days of cochlear implantation.
I was invited to Vienna by her to observe some of her
excellent results and spent an exciting week at the begin-
ning of my career. Professor Hochmair is President and CEO
of MED-EL Corporation. She has continued to improve
cochlear implant and electrode design and has incorpo-
rated the latest coding strategies.
Dr. Blake Wilson is a master at developing new coding
strategies as they apply to cochlear implants and deter-
mining how to assess them. He has been continuously sup-
ported by the National Institutes of Health. He has kept his
invaluable research in the public sector so as to have it
available to anyone.
Dr. Fred Linthicum was one of my fellowship mentors
and one of the preeminent temporal bone histopathologists
in the world. Some of the temporal bones from my earliest
cochlear implant patients are among his collection. His
studies have provided insight into what is stimulated by a
cochlear implant (the ganglion cell bodies) and the changes
that are the result of the insertion and presence of the
implant.
Dr. David Pisoni has been my colleague in the DeVault
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work, it would be a combination of sophisticated elec-
tronics coupled with limitless brain potential (“the ear is
connected to the brain”). He also helped launch our NIDCD
Training grant which supported many of our residents and
researchers including Dr. Ted Meyer, Dr. Aaron Moberly, Dr.
Michael Harris, Bethany Colson, Shirley Henning, and Dr.
William Kronenberger who have made significant contribu-
tions to this issue.
Dr. Karen Iler-Kirk directed the DeVault Otologic Labo-
ratories for many years prior to becoming Chair of Speech
and Hearing at the University of Illinois. She is directly
responsible for many of our NIDCD studies.
Amy McConkey Robbins helped launch our pediatric
cochlear implant program some 35 years ago and has added
greatly to our understanding of how a cochlear implant
habilitation program augments this exciting technology for
children.
Fan Gang Zeng is a long-time research collaborator. He
was previously with the House Ear Institute and is now with
UC Irvine.
Much remains to be accomplished, but the validity of
establishing a complex interdisciplinary team pooling their
expertise, which has been our model from the very begin-
ning, is clearly in evidence.
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